K+S Valuation
Is SDF undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of SDF when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SDF (CHF20.88) is trading below our estimate of fair value (CHF55.61)
Significantly Below Fair Value: SDF is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SDF?
Other financial metrics that can be useful for relative valuation.
| What is SDF's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | €1.91b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.6x |
| Enterprise Value/EBITDA | 4.3x |
| PEG Ratio | 6x |
Price to Sales Ratio vs Peers
How does SDF's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 2.5x | ||
CLN Clariant | 1x | 5.0% | CHF 4.4b |
VETN Vetropack Holding | 0.7x | 2.8% | CHF 612.6m |
EMSN EMS-CHEMIE HOLDING | 7.5x | 3.9% | CHF 16.6b |
CPHN CPH Group | 0.6x | -7.0% | CHF 384.9m |
SDF K+S | 0.5x | 0.9% | CHF 1.9b |
Price-To-Sales vs Peers: SDF is good value based on its Price-To-Sales Ratio (0.5x) compared to the peer average (2.5x).
Price to Earnings Ratio vs Industry
How does SDF's PE Ratio compare vs other companies in the European Chemicals Industry?
Price-To-Sales vs Industry: SDF is good value based on its Price-To-Sales Ratio (0.5x) compared to the European Chemicals industry average (1.1x).
Price to Sales Ratio vs Fair Ratio
What is SDF's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.5x |
| Fair PS Ratio | 0.4x |
Price-To-Sales vs Fair Ratio: SDF is expensive based on its Price-To-Sales Ratio (0.5x) compared to the estimated Fair Price-To-Sales Ratio (0.4x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | CHF 20.88 | CHF 12.71 -39.1% | 25.3% | CHF 17.99 | CHF 7.10 | n/a | 17 |
| Aug ’25 | CHF 20.88 | CHF 14.23 -31.8% | 20.8% | CHF 19.48 | CHF 9.74 | n/a | 17 |
| Jul ’25 | CHF 20.88 | CHF 14.65 -29.8% | 18.2% | CHF 19.24 | CHF 9.62 | n/a | 17 |
| Jun ’25 | CHF 20.88 | CHF 14.98 -28.3% | 17.5% | CHF 19.58 | CHF 9.79 | n/a | 17 |
| May ’25 | CHF 20.88 | CHF 15.09 -27.7% | 17.2% | CHF 19.52 | CHF 9.76 | n/a | 17 |
| Apr ’25 | CHF 20.88 | CHF 15.11 -27.6% | 16.9% | CHF 19.43 | CHF 9.72 | n/a | 16 |
| Mar ’25 | CHF 20.88 | CHF 15.56 -25.5% | 20.6% | CHF 21.44 | CHF 10.25 | n/a | 16 |
| Feb ’25 | CHF 20.88 | CHF 15.56 -25.5% | 20.6% | CHF 21.44 | CHF 10.25 | n/a | 16 |
| Jan ’25 | CHF 20.88 | CHF 16.82 -19.4% | 17.1% | CHF 21.49 | CHF 12.15 | n/a | 16 |
| Dec ’24 | CHF 20.88 | CHF 17.56 -15.9% | 15.7% | CHF 22.18 | CHF 12.54 | n/a | 16 |
| Nov ’24 | CHF 20.88 | CHF 18.49 -11.5% | 15.7% | CHF 23.76 | CHF 15.21 | n/a | 16 |
| Oct ’24 | CHF 20.88 | CHF 18.82 -9.8% | 16.3% | CHF 23.96 | CHF 14.38 | n/a | 16 |
| Sep ’24 | CHF 20.88 | CHF 18.82 -9.8% | 16.3% | CHF 23.96 | CHF 14.38 | n/a | 16 |
| Aug ’24 | CHF 20.88 | CHF 18.39 -11.9% | 15.9% | CHF 23.96 | CHF 14.38 | CHF 20.88 | 16 |
| Jul ’24 | CHF 20.88 | CHF 19.69 -5.7% | 15.8% | CHF 25.50 | CHF 15.69 | CHF 20.88 | 16 |
| Jun ’24 | CHF 20.88 | CHF 20.17 -3.4% | 17.6% | CHF 26.24 | CHF 16.23 | CHF 20.88 | 16 |
| May ’24 | CHF 20.88 | CHF 23.19 +11.1% | 17.2% | CHF 29.51 | CHF 16.72 | CHF 20.88 | 16 |
| Apr ’24 | CHF 20.88 | CHF 24.02 +15.0% | 15.7% | CHF 29.92 | CHF 16.95 | CHF 20.88 | 16 |
| Mar ’24 | CHF 20.88 | CHF 24.82 +18.8% | 15.7% | CHF 34.57 | CHF 19.65 | CHF 20.88 | 15 |
| Feb ’24 | CHF 18.20 | CHF 25.22 +38.6% | 16.0% | CHF 34.94 | CHF 19.87 | CHF 20.88 | 15 |
| Jan ’24 | CHF 18.20 | CHF 25.55 +40.4% | 15.2% | CHF 34.54 | CHF 20.04 | CHF 20.88 | 15 |
| Dec ’23 | CHF 18.20 | CHF 25.11 +38.0% | 15.3% | CHF 34.34 | CHF 19.92 | CHF 20.88 | 14 |
| Nov ’23 | CHF 18.20 | CHF 26.92 +47.9% | 19.8% | CHF 37.24 | CHF 20.58 | CHF 20.88 | 15 |
| Oct ’23 | CHF 18.20 | CHF 27.98 +53.7% | 23.8% | CHF 42.67 | CHF 19.18 | CHF 20.88 | 15 |
| Sep ’23 | CHF 18.20 | CHF 27.53 +51.3% | 26.1% | CHF 43.11 | CHF 18.02 | CHF 20.88 | 15 |
| Aug ’23 | CHF 18.20 | CHF 29.01 +59.4% | 28.6% | CHF 44.10 | CHF 15.86 | CHF 20.88 | 15 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.